Atea Pharmaceuticals, Inc. (AVIR) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2022 | $1.94M | +48475.0% |
| 2021 | $4.0K | -84.6% |
| 2020 | $26.0K | +1200.0% |
| 2019 | $2.0K | -83.3% |
| 2018 | $12.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2022 | $1.94M | +48475.0% |
| 2021 | $4.0K | -84.6% |
| 2020 | $26.0K | +1200.0% |
| 2019 | $2.0K | -83.3% |
| 2018 | $12.0K | — |